These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35390065)

  • 1. Association of colorectal cancer with genetic and epigenetic variation in PEAR1-A population-based cohort study.
    Yang WY; Izzi B; Bress AP; Thijs L; Citterio L; Wei FF; Salvi E; Delli Carpini S; Manunta P; Cusi D; Hoylaerts MF; Luttun A; Verhamme P; Hardikar S; Nawrot TS; Staessen JA; Zhang ZY
    PLoS One; 2022; 17(4):e0266481. PubMed ID: 35390065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEAR1 is not a major susceptibility gene for cardiovascular disease in a Flemish population.
    Yang WY; Petit T; Cauwenberghs N; Zhang ZY; Sheng CS; Thijs L; Salvi E; Izzi B; Vandenbriele C; Wei FF; Gu YM; Jacobs L; Citterio L; Delli Carpini S; Barlassina C; Cusi D; Hoylaerts MF; Verhamme P; Kuznetsova T; Staessen JA
    BMC Med Genet; 2017 Apr; 18(1):45. PubMed ID: 28449647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation of PEAR1 DNA methylation influences platelet and leukocyte function.
    Izzi B; Gianfagna F; Yang WY; Cludts K; De Curtis A; Verhamme P; Di Castelnuovo A; Cerletti C; Donati MB; de Gaetano G; Staessen JA; Hoylaerts MF; Iacoviello L;
    Clin Epigenetics; 2019 Oct; 11(1):151. PubMed ID: 31665082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allele-specific DNA methylation reinforces PEAR1 enhancer activity.
    Izzi B; Pistoni M; Cludts K; Akkor P; Lambrechts D; Verfaillie C; Verhamme P; Freson K; Hoylaerts MF
    Blood; 2016 Aug; 128(7):1003-12. PubMed ID: 27313330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEAR1 is not a human hypertension-susceptibility gene.
    Olivi L; Vandenbriele C; Gu YM; Salvi E; Carpini SD; Liu YP; Jacobs L; Jin Y; Thijs L; Citterio L; Cusi D; Verhamme P; Staessen JA
    Blood Press; 2015 Feb; 24(1):61-4. PubMed ID: 25541647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-Specific PEAR1 Methylation Studies Reveal a Locus that Coordinates Expression of Multiple Genes.
    Izzi B; Noro F; Cludts K; Freson K; Hoylaerts MF
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29614055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes.
    Lewis JP; Ryan K; O'Connell JR; Horenstein RB; Damcott CM; Gibson Q; Pollin TI; Mitchell BD; Beitelshees AL; Pakzy R; Tanner K; Parsa A; Tantry US; Bliden KP; Post WS; Faraday N; Herzog W; Gong Y; Pepine CJ; Johnson JA; Gurbel PA; Shuldiner AR
    Circ Cardiovasc Genet; 2013 Apr; 6(2):184-92. PubMed ID: 23392654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted deep sequencing of the PEAR1 locus for platelet aggregation in European and African American families.
    Keramati AR; Yanek LR; Iyer K; Taub MA; Ruczinski I; Becker DM; Becker LC; Faraday N; Mathias RA
    Platelets; 2019; 30(3):380-386. PubMed ID: 29553866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of PEAR1 genetic variants with platelet reactivity in response to dual antiplatelet therapy with aspirin and clopidogrel in the Chinese patient population after percutaneous coronary intervention.
    Yao Y; Tang XF; Zhang JH; He C; Ma YL; Xu JJ; Song Y; Liu R; Meng XM; Song L; Chen J; Wang M; Xu B; Gao RL; Yuan JQ
    Thromb Res; 2016 May; 141():28-34. PubMed ID: 26962983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Variation in the Platelet Endothelial Aggregation Receptor 1 Gene Results in Endothelial Dysfunction.
    Fisch AS; Yerges-Armstrong LM; Backman JD; Wang H; Donnelly P; Ryan KA; Parihar A; Pavlovich MA; Mitchell BD; O'Connell JR; Herzog W; Harman CR; Wren JD; Lewis JP
    PLoS One; 2015; 10(9):e0138795. PubMed ID: 26406321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and epigenetic variation in the DNMT3B and MTHFR genes and colorectal adenoma risk.
    Ho V; Ashbury JE; Taylor S; Vanner S; King WD
    Environ Mol Mutagen; 2016 May; 57(4):261-8. PubMed ID: 27062459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variants of PEAR1 Are Associated With Outcome in Patients With ACS and Stable CAD Undergoing PCI.
    Stimpfle F; Bauer M; Rath D; Schaeffeler E; Schwab M; Gawaz M; Winter S; Geisler T
    Front Pharmacol; 2018; 9():490. PubMed ID: 29867494
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel.
    Xu K; Ye S; Zhang S; Yang M; Zhu T; Kong D; Chen J; Xu L; Li J; Zhu H; Wang F; Yang L; Zhang J; Fan Y; Ying L; Hu X; Zhang X; Chan NC; Li C
    Circ Cardiovasc Interv; 2019 May; 12(5):e007019. PubMed ID: 31018667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with increased platelet aggregability.
    Herrera-Galeano JE; Becker DM; Wilson AF; Yanek LR; Bray P; Vaidya D; Faraday N; Becker LC
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1484-90. PubMed ID: 18511696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variants of PEAR1 are Associated with Platelet Function and Antiplatelet Drug Efficacy: A Systematic Review and Meta-Analysis.
    Xiang Q; Zhou S; Lewis JP; Shuldiner AR; Ren G; Cui Y
    Curr Pharm Des; 2017; 23(44):6815-6827. PubMed ID: 28820077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic mutations in PEAR1 associated with cardiovascular outcomes in Chinese patients with acute coronary syndrome.
    Nie XY; Li JL; Qin SB; Fu Y; Liang GK; Shi LW; Shao H; Liu J; Lu Y
    Thromb Res; 2018 Mar; 163():77-82. PubMed ID: 29407631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
    de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
    Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
    Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Long-Term Cerebrovascular Outcomes in Patients With Minor Stroke or Transient Ischemic Attack.
    Zhang XG; Gu JY; Fu QQ; Chen SW; Xue J; Jiang SS; Kong YM; Li YM; Yue YH
    Front Neurol; 2021; 12():649056. PubMed ID: 34135847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.